Filing Details
- Accession Number:
- 0001127602-12-035055
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2012-12-26 21:31:12
- Reporting Period:
- 2012-12-24
- Filing Date:
- 2012-12-26
- Accepted Time:
- 2012-12-26 21:31:12
- SEC Url:
- Form 4 Filing
Issuer
Cik | Name | Symbol | Sector (SIC) | IRS No |
---|---|---|---|---|
1082554 | United Therapeutics Corp | UTHR | Pharmaceutical Preparations (2834) | 521984749 |
Insiders
Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
---|---|---|---|---|---|---|---|
1106578 | A Martine Rothblatt | C/O United Therapeutics Corporation 1040 Spring Street Silver Spring MD 20910 | Ceo | Yes | Yes | No | No |
Reported Non-Derivative Transactions
Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|---|---|---|---|---|---|
Common Stock | Acquisiton | 2012-12-24 | 3,000 | $52.45 | 702,602 | No | 4 | P | Indirect | By Trusts |
Common Stock | Acquisiton | 2012-12-26 | 3,000 | $52.34 | 705,602 | No | 4 | P | Indirect | By Trusts |
Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|
No | 4 | P | Indirect | By Trusts |
No | 4 | P | Indirect | By Trusts |
Reported Non-Derivative Holdings
Sec. Name | Remaning Holdings | Nature of Ownership | Explanation |
---|---|---|---|
Common Stock | 0 | Direct |
Footnotes
- Shares were purchased pursuant to pre-arranged 10b5-1 trading plans entered into by trusts beneficially owned by the reporting person and the reporting person's spouse.
- This transaction was executed in multiple trades at prices ranging from $52.27 to $52.58. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
- Shares held by the reporting person in GRATs and PMTs.
- This transaction was executed in multiple trades at prices ranging from $52.08 to $52.67. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.